✦ LIBER ✦

Double blind pilot study of eicosapentaenoic acid (EPA) as the sole treatment for schizophrenia

✍ Scribed by S. Shah; C.N. Ramchand; M. Peet

Book ID: 119553884
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 67 KB
Volume: 41
Category: Article
ISSN: 0920-9964
DOI: 10.1016/s0920-9964(00)90360-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two double-blind placebo-controlled pilo

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

✍ Malcolm Peet; Jan Brind; C.N. Ramchand; Sandeep Shah; G.K. Vankar 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Eicosapentaenoic acid (EPA) as an adjunc

Eicosapentaenoic acid (EPA) as an adjunct in the treatment of schizophrenia

✍ S. Shah; G.K. Vankar; S.D. Telang; C.N. Ramchand; M. Peet 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Eicosapentaenoic acid in the treatment o

Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results

✍ Malcolm Peet 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Conjugated estrogens as adjuvant therapy

Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study

✍ Mario R. Louzã; Ana Paula Marques; Hélio Elkis; Débora Bassitt; Mara Diegoli; Wa 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 100 KB

A Double-Blind, Placebo-Controlled Pilot

A Double-Blind, Placebo-Controlled Pilot Study of Carbamazepine for the Treatment of Alcohol Dependence

✍ Timothy I. Mueller; Robert L. Stout; Sandra Rudden; Richard A. Brown; Alan Gordo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

Rifaximin for the treatment of active po

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study

✍ Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with